{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T05:50:53Z","timestamp":1768283453447,"version":"3.49.0"},"reference-count":36,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2012,2,2]],"date-time":"2012-02-02T00:00:00Z","timestamp":1328140800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0030804","type":"journal-article","created":{"date-parts":[[2012,2,2]],"date-time":"2012-02-02T21:56:51Z","timestamp":1328219811000},"page":"e30804","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":48,"title":["Parallel Evolution under Chemotherapy Pressure in 29 Breast Cancer Cell Lines Results in Dissimilar Mechanisms of Resistance"],"prefix":"10.1371","volume":"7","author":[{"given":"B\u00e1lint","family":"Tegze","sequence":"first","affiliation":[]},{"given":"Zolt\u00e1n","family":"Sz\u00e1ll\u00e1si","sequence":"additional","affiliation":[]},{"given":"Ir\u00e9n","family":"Haltrich","sequence":"additional","affiliation":[]},{"given":"Zs\u00f3fia","family":"P\u00e9nzv\u00e1lt\u00f3","sequence":"additional","affiliation":[]},{"given":"Zsuzsa","family":"T\u00f3th","sequence":"additional","affiliation":[]},{"given":"Istv\u00e1n","family":"Lik\u00f3","sequence":"additional","affiliation":[]},{"given":"Bal\u00e1zs","family":"Gy\u0151rffy","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2012,2,2]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1002\/ijc.21570","article-title":"Gene expression profiling of 30 cancer cell lines predicts resistance towards 11 anticancer drugs at clinically achieved concentrations.","volume":"118","author":"B Gyorffy","year":"2006","journal-title":"Int J Cancer"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"15990","DOI":"10.1074\/jbc.M011143200","article-title":"ATP-bound topoisomerase II as a target for antitumor drugs.","volume":"276","author":"HM Wang","year":"2001","journal-title":"Journal of Biological Chemistry"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"187","DOI":"10.5414\/CPP38187","article-title":"Diverse effects of P-glycoprotein inhibitory agents on human leukemia cells expressing the multidrug resistance protein (MRP).","volume":"38","author":"G Lehne","year":"2000","journal-title":"International Journal of Clinical Pharmacology and Therapeutics"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1126\/science.6137059","article-title":"Cell-Surface P-Glycoprotein Associated with Multidrug Resistance in Mammalian-Cell Lines.","volume":"221","author":"N Kartner","year":"1983","journal-title":"Science"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"7542","DOI":"10.1038\/sj.onc.1208908","article-title":"Prediction of doxorubicin sensitivity in breast tumors based on gene expression profiles of drug-resistant cell lines correlates with patient survival.","volume":"24","author":"B Gyorffy","year":"2005","journal-title":"Oncogene"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1093\/jnci\/91.19.1604","article-title":"Lung resistance-related protein: Determining its role in multidrug resistance.","volume":"91","author":"WS Dalton","year":"1999","journal-title":"Journal of the National Cancer Institute"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1054\/drup.2000.0156","article-title":"The (patho)physiological functions of the MRP family.","volume":"3","author":"J Renes","year":"2000","journal-title":"Drug Resistance Updates"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1093\/jnci\/92.16.1295","article-title":"A family of drug transporters: The multidrug resistance-associated proteins.","volume":"92","author":"P Borst","year":"2000","journal-title":"Journal of the National Cancer Institute"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/sj.bjc.6605478","article-title":"PSMB7 is associated with anthracycline resistance and is a prognostic biomarker in breast cancer.","volume":"102","author":"G Munkacsy","year":"2010","journal-title":"Br J Cancer"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/0006-291X(86)90981-2","article-title":"Prevention of Doxorubicin-Induced Killing of Mcf-7 Human-Breast Cancer-Cells by Oxygen Radical Scavengers and Iron Chelating-Agents.","volume":"135","author":"JH Doroshow","year":"1986","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1054\/bjoc.1999.0947","article-title":"Modulation of DNA topoisomerase II activity and expression in melanoma cells with acquired drug resistance.","volume":"82","author":"H Lage","year":"2000","journal-title":"British Journal of Cancer"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/bjc.1995.9","article-title":"Reduced Topoisomerase-Ii Activity in Multidrug-Resistant Human Nonsmall Cell Lung-Cancer Cell-Lines.","volume":"71","author":"EWHM Eijdems","year":"1995","journal-title":"British Journal of Cancer"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nm.2090","article-title":"Amplification of LAPTM4B and YWHAZ contributes to chemotherapy resistance and recurrence of breast cancer.","volume":"16","author":"Y Li","year":"2010","journal-title":"Nat Med"},{"key":"ref14","first-page":"389","article-title":"Levels of multidrug resistance (MDR1) P-glycoprotein expression by human breast cancer correlate with in vitro resistance to taxol and doxorubicin.","volume":"4","author":"E Mechetner","year":"1998","journal-title":"Clin Cancer Res"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ygyno.2003.11.053","article-title":"Expression of multidrug resistance-1 protein inversely correlates with paclitaxel response and survival in ovarian cancer patients: a study in serial samples.","volume":"93","author":"RT Penson","year":"2004","journal-title":"Gynecol Oncol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1158\/1078-0432.298.11.1","article-title":"Class III beta-tubulin overexpression is a prominent mechanism of paclitaxel resistance in ovarian cancer patients.","volume":"11","author":"S Mozzetti","year":"2005","journal-title":"Clin Cancer Res"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1172\/JCI119642","article-title":"Taxol-resistant epithelial ovarian tumors are associated with altered expression of specific beta-tubulin isotypes.","volume":"100","author":"M Kavallaris","year":"1997","journal-title":"J Clin Invest"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1200\/JCO.1999.17.6.1786","article-title":"Paclitaxel resistance in non-small-cell lung cancer associated with beta-tubulin gene mutations.","volume":"17","author":"M Monzo","year":"1999","journal-title":"J Clin Oncol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"8315","DOI":"10.1073\/pnas.0408974102","article-title":"Microtubule-associated protein tau: a marker of paclitaxel sensitivity in breast cancer.","volume":"102","author":"R Rouzier","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1200\/JCO.2009.22.4725","article-title":"Efficacy of neoadjuvant Cisplatin in triple-negative breast cancer.","volume":"28","author":"DP Silver","year":"2010","journal-title":"J Clin Oncol"},{"key":"ref21","article-title":"Multifactorial Approach to Predicting Resistance to Anthracyclines.","author":"C Desmedt","year":"2011","journal-title":"J Clin Oncol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"5923","DOI":"10.1073\/pnas.0601231103","article-title":"Thousands of samples are needed to generate a robust gene list for predicting outcome in cancer.","volume":"103","author":"L Ein-Dor","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nm.1908","article-title":"A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer.","volume":"15","author":"P Farmer","year":"2009","journal-title":"Nat Med"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1038\/nm1491","article-title":"Genomic signatures to guide the use of chemotherapeutics.","volume":"12","author":"A Potti","year":"2006","journal-title":"Nat Med"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/nm0111-135","article-title":"Retraction: Genomic signatures to guide the use of chemotherapeutics.","volume":"17","author":"A Potti","year":"2011","journal-title":"Nat Med"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s10549-009-0445-7","article-title":"Clinical evaluation of chemotherapy response predictors developed from breast cancer cell lines.","volume":"121","author":"C Liedtke","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1158\/0008-5472.CAN-10-1623","article-title":"Multiple mutations and bypass mechanisms can contribute to development of acquired resistance to MET inhibitors.","volume":"71","author":"J Qi","year":"2011","journal-title":"Cancer Res"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1126\/science.1141478","article-title":"MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling.","volume":"316","author":"JA Engelman","year":"2007","journal-title":"Science"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"20932","DOI":"10.1073\/pnas.0710370104","article-title":"MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib.","volume":"104","author":"J Bean","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref30","first-page":"559","article-title":"[The problem of multiple testing and solutions for genome-wide studies].","volume":"146","author":"B Gyorffy","year":"2005","journal-title":"Orv Hetil"},{"key":"ref31","first-page":"306","article-title":"The mathematical theory of communication. 1963.","volume":"14","author":"CE Shannon","year":"1997","journal-title":"MD Comput"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/ng1768","article-title":"Genetic clonal diversity predicts progression to esophageal adenocarcinoma.","volume":"38","author":"CC Maley","year":"2006","journal-title":"Nat Genet"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1200\/JCO.2009.25.5414","article-title":"Overall survival and post-progression survival in advanced breast cancer: a review of recent randomized clinical trials.","volume":"28","author":"ED Saad","year":"2010","journal-title":"J Clin Oncol"},{"key":"ref34","first-page":"105","article-title":"Tumor heterogeneity: causes and consequences.","volume":"1805","author":"A Marusyk","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1038\/sj.bjc.6605912","article-title":"How Darwinian models inform therapeutic failure initiated by clonal heterogeneity in cancer medicine.","volume":"103","author":"M Gerlinger","year":"2010","journal-title":"Br J Cancer"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/CCO.0b013e32833fb384","article-title":"Implication of tumor microenvironment in the resistance to chemotherapy in breast cancer patients.","volume":"22","author":"F Andre","year":"2010","journal-title":"Curr Opin Oncol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0030804","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T07:53:27Z","timestamp":1686729207000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0030804"}},"subtitle":[],"editor":[{"given":"Marianne","family":"Koritzinsky","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2012,2,2]]},"references-count":36,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2012,2,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0030804","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,2]]}}}